Generated by AI
Lexaria Bioscience Corp. is a biotechnology company focused on improving how active pharmaceutical ingredients are delivered and absorbed in the body. Its core platform, DehydraTECH, is designed to enhance oral bioavailability and can be applied across a range of compounds, including cannabinoids, nicotine, vitamins, pain medications, hormones, antivirals, and other lipophilic molecules. The company works through intellectual property licensing, business-to-business product development, and research and development activities, supporting pharmaceutical, nutraceutical, and consumer health applications. Lexaria Bioscience Corp. is headquartered in Kelowna, British Columbia, Canada, and its current work centers on developing and licensing drug delivery technologies for partners seeking more efficient oral formulations and improved therapeutic performance.
Website740 McCurdy Road
Kelowna, BC, V1X 2P7
Canada
The latest articles about LEXX.
Summary of Oct 28's posts. Generated by AI.
Summary of Oct 16's posts. Generated by AI.
Summary of Oct 16's posts. Generated by AI.
Investors talking about LEXX also mention these. Each card shows that asset’s own numbers for the past 24 hours.
Valuation and earnings.